A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model

Developments of a water-maze procedure for studying spatial learning in the rat

Richard Morris · Journal of Neuroscience Methods · 1984 · 7.2K citations

Life Sciences, Neurobiology, Neuroscience +14

Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

Konrad Talbot, Hoau-Yan Wang, Hala Kazi et al. · Journal of Clinical Investigation · 2012 · 1.8K citations · Full text

Medicine, Neurology, Neuroscience +17

Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling

Aileen M. Moloney, Rebecca J. Griffin, Suzanne Timmons et al. · Neurobiology of Aging · 2008 · 767 citations

Life Sciences, Molecular Biology, Neuroscience +17

The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease

Paula L. McClean, Vadivel Parthsarathy, Émilie Faivre et al. · Journal of Neuroscience · 2011 · 686 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans

Brian Finan, Tao Ma, Nickki Ottaway et al. · Science Translational Medicine · 2013 · 675 citations

Medicine, Pharmacokinetics, Pharmacology +16